INVESTABOT
Equity Research
XNAS · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
Moderna (MRNA) had 1 Form 144 pre-sale notice filed on 2026-07-15. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing refe…
Moderna (MRNA) had 1 Form 144 pre-sale notice filed on 2026-05-08. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Moderna (MRNA) had 1 Form 144 pre-sale notice filed on 2026-06-15. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing refe…
Moderna (MRNA) had 1 Form 144 pre-sale notice filed on 2026-06-18. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Moderna (MRNA) had 1 Form 144 pre-sale notice filed on 2026-06-04. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing refe…
Moderna (MRNA) had 1 Form 144 pre-sale notice filed on 2026-05-21. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Moderna (MRNA) had 1 Form 144 pre-sale notice filed on 2026-05-15. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing refe…
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 8/6/2026 | Bancel Stephane | Chief Executive Officer | OPTION_EXERCISE | 252,469 | $19 | $4,834,781 |
| 8/6/2026 | Bancel Stephane | Chief Executive Officer | OPTION_EXERCISE | -187,541 | — | — |
| 8/6/2026 | Bancel Stephane | Chief Executive Officer | OPTION_EXERCISE | -64,928 | — | — |
| 8/5/2026 | Bancel Stephane | Chief Executive Officer | OPTION_EXERCISE | 499,246 | $19 | $9,560,561 |
| 8/5/2026 | Bancel Stephane | Chief Executive Officer | SELL | -147,473 | $56 | $8,289,457 |
| 8/5/2026 | Bancel Stephane | Chief Executive Officer | SELL | -124,838 | $57 | $7,110,772 |
| 8/5/2026 | Bancel Stephane | Chief Executive Officer | SELL | -39,891 | $58 | $2,318,465 |
| 8/5/2026 | Bancel Stephane | Chief Executive Officer | SELL | -187,044 | $59 | $10,996,317 |
| 8/5/2026 | Bancel Stephane | Chief Executive Officer | OPTION_EXERCISE | -370,853 | — | — |
| 8/5/2026 | Bancel Stephane | Chief Executive Officer | OPTION_EXERCISE | -128,393 | — | — |
| 7/15/2026 | Hoge Stephen | President | OPTION_EXERCISE | 37,226 | $19 | $712,878 |
| 7/15/2026 | Hoge Stephen | President | OPTION_EXERCISE | 16,110 | $19 | $308,507 |
| 7/15/2026 | Hoge Stephen | President | SELL | -53,336 | $68 | $3,605,514 |
| 7/15/2026 | Hoge Stephen | President | OPTION_EXERCISE | -37,226 | — | — |
| 7/15/2026 | Hoge Stephen | President | OPTION_EXERCISE | -16,110 | — | — |
| 7/8/2026 | McDonnell Michael R. | — | GRANT | 7,415 | — | — |
| 7/8/2026 | McDonnell Michael R. | — | GRANT | 1,618 | — | — |
| 7/8/2026 | McDonnell Michael R. | — | GRANT | 5,733 | — | — |
| 7/5/2026 | Banque Soria Ester | Chief Commercial Officer | GRANT | 18,658 | — | — |
| 7/5/2026 | Banque Soria Ester | Chief Commercial Officer | GRANT | 38,364 | — | — |
| Date | Filer | Relationship | Est. shares | Filing |
|---|---|---|---|---|
| 8/5/2026 | Bancel Stephane | — | 499,246 | SEC |
| 7/15/2026 | Hoge Stephen | — | 53,336 | SEC |
| 6/18/2026 | SAGAN PAUL | — | 25,770 | SEC |
| 6/15/2026 | Hoge Stephen | — | 53,336 | SEC |
| 6/4/2026 | Klinger Shannon Thyme | — | 3,471 | SEC |
| 5/21/2026 | Flagship Pioneering, LLC | — | 9,263 | SEC |
| 5/15/2026 | Hoge Stephen | — | 53,336 | SEC |
| 5/8/2026 | SAGAN PAUL | — | 36,759 | SEC |
| 5/1/2026 | Hussain Abbas | — | 5,682 | SEC |